13D Filing: Orbimed Israel Biofund GP Limited Partnership and Novus Therapeutics Inc. (NVUS)

Page 9 of 9

Page 9 of 9 – SEC Filing

SCHEDULE II
The business and operations of OrbiMed Israel BioFund GP Limited Partnership are managed by the executive officers and directors of its general partner, OrbiMed Israel GP Ltd.

Follow Eledon Pharmaceuticals Inc. (NASDAQ:ELDN)

Page 9 of 9